<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 379 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page378.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=379">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 379 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 379</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=379"><img src="../thumb/379.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>342 / 2020-04                                             Enzymes / Poison Antidotes / Others - 27 / 28 / 29
   Indications: Hunter syndr. (Mucopolysaccharidosis II, MPS II).  antibody format.3 mnthly., pts. test. poss.for alglucosidase alfa-  photophob., myopia, incr. acrimat., tinnit., dyspn., cough, hoarsen., pha-
   (S4) CONC.FOR SOL.FOR INFUS, 44/31/0500  specif. IgE antibod. who exper.anaphylact.reacts.may be rechall.   ryngolaryng.pain, throat irrit., resp.tract-/sinus congest., post nas.drip,
   717137-001: 2 mg/ml, 1x3 ml vial, R28 687,64  und.close clinic.supervis., sev.card.effs. incl. arrest/death or requir.  rhinorrh., snor., GI disturbs. incl. haematemes., skin rash, Stev/John.,
   Dosage: For use by exper.physic.only. Admin.in an appropr. clinic.  card.resuscit./ defibrillat. assoc.with gen.anaesthes.for centr. ven.  erythema multiforme, prurit., acne, hyperhidros., night sweats, joint
   sett. with resus.equipm.     cathet.placem./other surg.proced.in inft.-onset Pompe dis.pts.with   stiffn., musc.spasm, chest wall pain, costochondrit., glycosur., noctur.,
   Recomm.dos.: 0,5 mg/kg bw every wk.by IV infus. over 3 hr. period.  card.hypertrophy, fluid overload.  polyur., menorrhag., vag.discharge, sex.dysfunct., fatig., chest discomf.,
   which may be grad.reduc.to 1 hr. if no IARs observ. Infus.at home may   chest pain, pyrex., feel.cold, asthen., circadian rhythm sleep disord., mal-
   be consid.for pts. tolerat.their infus well.               aise, cyst, incr BP, ECG changes, liv.funct.abnorm., decr. platelet count,
   Side effects: Anaphylact. react., headache, dysrhythm, cyanos.,   incr.heart rate, incr.weight, abnorm. semen, C-reactive prot.incr., bld.
   tachycard., hyper-/hypotens., flush., wheez., dyspn., hypox., bron-  28   POISON ANTIDOTES  Ca decr. Post market. reports incl.hypersens.reacts., seiz., depress./
   chosp., tachypn., GI disords., urticar., rash, prurit., erythema, chest   mania/psychos/hallucinat./paranoia, delus., homicid.ideat., aggress./
   pain.infus.-assoc.reacts, pyrex., infus. site reacts., fac./periph.oed.  PARADOTE (MDR Listing)  anx./panic/suic. ideat & attempts, CV events
   Warnings and special precautions: Infus. assoc. reacts.  PARADOTE, Equity [P/S] &  Special precautions: Observ.for neuropsych. sympts. /worsen.of pre-
   (IARs), monit.pts.with sev.underly. airway dis./compromis.  N-acetylcysteine.  exist.psych.illn., discont. ther.if behav.changes/think.changes or suid.
   resp.funct.& only infus.in appropr. clinic.sett., limit./caref.  Indications: Paracet.overdos.  ideat. or behav.observ., monit.& support.care advis.until behav.sympts.
   monit.antihistam. & other sedat.use in pts.with sev.underly.  (S3) INJ. 44/32.16/0329. 200 mg/ml.  resolv., smok.cessat.may alt.warfar. pharmacokinet.theref.more reg.INR
   airway dis., consid.delay.of infus.in pts.with ac.febrile resp.   718898-001: 10x10 ml, R3 653,16  monitor.reqd., safety & effic.of other concom.smok.cessat.ther. not stud.,
   illn., pts.using supplement.O2 should have this readily avail.,   Dosage: Adults: Admin. only in dextrose 5%/ 0,9% NaCl/0,3% pot.  sev.ren.impairm., elderly, smok.cessat. with/-out treatm.assoc.with var.
   pts.develop.IgM/IgG antibod.at high. risk of infus./other adv.re-  chlor.with 0,9%NaCl/ 0,3% pot.chlor.with gluc.5%.  sympts.& study does not disting.betw.drug assoc.events & those as-
   acts., discont. immed. if sev.allerg./anaphylact.-type reacts.occ. &   Init. 150 mg/kg bm.IV infus.in 200 ml over 15 min., then 50 mg/kg   soc.with nicotine withdr., adv.pt.to discont. treatm. & seek med.care
   init. approp. treatm, no clinic.exper.in pts.with ren./ hepat.insuffic.&   bm in 500 ml over next 4 hrs., then 100 mg/kg bm in 1 L over next   if sympts of hypersens. incl.angioed./rash with mucos.les.occ., pt.to
   pts&lt;5/&gt;65 yrs., safety & effic. not eval.in pregn/lactat./pts.&lt;16 mnths.  16 hrs. Modify quantit. IV fluid used for childr.accord.to age & bm.  notify prescrib.if new/worsening CV effects occ.
                                                              Drug interactions: Naus.incid.doubled with concom. bupropion,
   FABRAZYME, Sanofi-Aventis [P/S]  Contraindications: Safety in pregn. & lactat.not est.  decr.in aveg.systol.BP & incr. headache, GI effs.& fatig.with other
   Agalsidase beta              Side effects: Hypersens./anaphylact.reacts.incl. angioed./skin re-  concom. nicotine replacem.ther(NRT)
   Indications: Fabry dis.      acts., hypo-/hypertens., card. arrest, ECG chang., tachycard., flush.,   See also MDR page 597.
   (S4) POWD.FOR INJ, 46/31/0583, 0584  sweat., GI disturbs., fev., syncope, arthralg., liv.funct. disturbs., aci-
   716559-001: 5 mg/5 ml, 1x5 ml vial, R5 970,34  dos., hypokalaem., convuls., eye disords.  DYSPORT, Litha [P/S] &
   716558-001: 35 mg/20 ml, 1x20 ml vial, R41 792,40  Special precautions: Concom.meds.induc.liv. enzym./ reg.al-  Clostridium botulinum type A toxin-haemagglutinin complex.
   Dosage: Do not invert/swirl/shake vial., do not mix. with other meds.  coh.consumpt.above recomm.lev., plasma paracetamol lev.to be   Indications: Dynam.equinus foot deform.due to spasticity in am-
   in same infus., ref.to PI for reconstit.instruct.  determ.4 hrs aft. ingest., pts.with signif.ingest.to be monit.for at   bul.paed.cerebr.palsy pts.2 yrs.& old., arm sympts.assoc.with fo-
                                                         +
   Recom.dos: 1,0 mg/kg bw.infus.every 2 wks.as a slow IV infus.  least 96 hrs., asthma/bronchosp.hist., monit. plasma K  conc.,   cal spastic.in conjunct. with physiother., adult spasmod.torticoll.,
   over 2 hrs./long.            monit./treatm.for anaphylact. reacts./ bronchosp./rash., malnutrit.,   temp.improvem.in appear.of mod.-sev.glabell.lines assoc.with pro-
   Contraindications: Do not admin with concom. chloroquine/ ami-  incompat. with some metals/rubber/oxygen/oxidis.subst., some   cer.& corrugat.musc.activ.in adults &lt; 65 yrs., symptomat.treatm.
   odarone/benoquin/gentamycin, pregn.& lactat., safety & effic.not   antimicrob.& tetracycl.eith.physic.incompat./ may be inactivat.on   of axill.hyperhidros.
   eval.in pts.&lt; 8 yrs / pts.&gt; 65 yrs., no exper.in pts.with hepat. insuff.  mixt.with Paradote.  (S4) POWD.FOR INJ. 37/30.4/0683
   Side effects: Infus.-assoc.reacts., nasopharyngit., rhinit., anaphy-  See also MDR page 310.  707625-001: 500 U/3 ml vial, R4 921,16
   lax., sev.allerg.reacts, angioed., CNS effs., incr.lacrimat., eye prurit.,   Dosage: Admin.IM by exper.specialist & in facility with adeq.re-
   ocul.hyperaem., tinnit., vertigo, auricul.swell., ear pain, tachycard.,   PARVOLEX, Aspen Pharmacare: Pharma) Pharmacare [P/S]  susitat.facilit. Dos.units specif.to preparat. & not interchang.with
   palpitat., bradycard., sinus bradycard., flush., hyper-/hypotens., pal-  N-acetylcysteine.  other botulin.type A toxins.
   lor, periph.coldn., dyspn., nas. congest., throat tightn., wheez., cough,   Indications: Paracet.overdos.  Paed cerebr.palsy spastic.: Init.recomm.dos: 20 units/ kg body
   exacerbat. dyspn., bronchosp., pharyngolaryng. pain, tachypn., URT   (S3) INJ. NX/34/156. 200 mg/ml.  weight in div.dos.betw.both calf musc. If one calf affect.use dos of 10
   congest., GI disturbs., skin & subcutan.tiss. disords. incl.maculopap-  788740-008: 10x10 ml, R3 960,42  units/kg body weight. Titrat.subseq.treatm.within range 10 -30 units/
   ul.rash/livedo reticular./ skin discolourat./leukocytoclast.vasculit.,   Dosage: Adults: Init. 150 mg/kg bm.IV infus.in 200 ml dextr. 5% over   kg div.betw.both legs. Max dos 1000 units/ pt. Target gastrocnem.
   extremity/ back/chest/musculoskelet.pain, myalg., musc. spasms/  15 min., then 50 mg/kg bm in 500 ml over next 4 hrs., then 100 mg/  primarily, consid.soleus & tibialis poster.for inject. Clin.improvem.
   tightn./stiffn., arthralg., chills, pyrex., fatig., chest discomf., feel.hot/  kg bm in 1 L over next 16 hrs. Modify quantit.IV fluid used for childr.  may be expect. &lt; 2wks. aft.inj.Rep.approx.every 16 wks. as req.to
   cold, periph. oedema, asthen., chest pain, fac.oed., hypertherm.,   accord.to age & bm.  maint.respons.but not more freq.than every 8 wks.
   influenza-like illn., infus.site pain/ react./ thrombos., malaise, oed.,   Contraindications: Ineffect.15 hrs.aft.overdos., safety in pregn.not est.  Arm spacticity: Recomm.dos: 1000 units in total distribut.
   decr.oxygen saturat.         Side effects: Rash, bronchosp., anaphylact. reacts., hypokalaem.,   amongst the follow.five muscl.: Biceps brachii: 300 - 400 units (0,6
   Warnings and special precautions: Developm. of lgG antibod.  ECG chang.  - 0,8 ml), Flexor digitorum profundus: 150 units (0,3 ml), Flexor digi-
   expect.in pts.with little/no resid. enz. activ., incr.risk of infus.-assoc.  Special precautions: Asthma/hist.thereof, monit. plasma K   +  torum superficialis: 150 - 250 units (0,3 - 0,5 ml), Flexor carpi ulnaris:
   reacts.in pts. with antibod.& caut.advis.on re-admin., monit. anti-  conc., not compat.with rubber & metals esp.iron/copper and nickel.  150 units (0,3 ml), Flexor carpi radialis: 150 units (0,3 ml).
   body status regular., discont.immed.if sev. allerg./ anaphylact.-type   All musc.except.biceps brachii should be inject.at one site, biceps
   reacts.occ.& init.approp. treatm, contains mannitol., pre-admin.of   should be inject.at two sites. Max dos. not to exceed 1000 units.
   NSAIDs/ antihistamin. &/ corticoster.advis.in some pts.for manag.  Clin.improvem.may be expect. &lt; 2wks. aft.inj. Rep.approx.every 16
   infus.-assoc.reacts.         29      OTHERS                wks. as req.to maint.respons.but not more freq. than every 12 wks.
   Drug interactions: Chloroquine/ amiodarone/ benoquin/ gentamy-  CHAMPIX (MDR Listing)  Spasmodic torticollis: Init.recomm.dos.: 500 units/pt. giv.as div.
   cin. inhibits intra-cell.alpha-galactosidase activ.        dos. & admin.to the two/ three most activ.neck musc.
                                DYSPORT (MDR Listing)         Rotational torticollis: 350 units in splenius capitis musc., ipsilateral
   HYALASE, (Mylan) Xixia [P/S]  SUBOXONE (MDR Listing)       to direct. of chin/head rotat.& 150 units in sternomastoid musc.
   Hyaluronidase.               ADCO SALINE, (AI Crit.Care) AI Ltd [P/S]  contralater. to rotat.
   Indications: Hypodermoclysis, prevent.post-partum haemorrh.,   Laterocollis: 350 units in ipsilateral splenius capitis musc. & 150 units
   radiography, obstet.anaesth., aid to loc.anaesth.in ophthalmol.&   Sodium chloride.  in ipsilateral sternomastoid musc. In cases assoc.with should.elevat.
                                Indications: Sngl.dose irrigat.sol.
   fract.reduct.                                              the ipsilateral trapezoid/levator scapulae musc.may also require
   (S4) INJ, H2874. 1500 iu/amp  (S1) IRRIGAT.SOL. 28/34/0577. 9 g/1 000 ml  treatm. Where inj.of three musc.reqd. distrib.dos. as 300 units in sp-
   731560-035: 10 amps. R4 281.47  831638-028: 30 ml, 25x30 ml, R145,33  lenius capitis, 100 units in sternomastoid and 100 units to 3rd musc.
   For further details refer to manuf.product lit.  BRIDION, MSD [P/S]  Retrocollis: 250 units in each splenius capitis musc. Bilat.splenii inj.
   METALYSE, Boehringer Ingelheim (Pty) Ltd  Sugammadex       may incr.risk of neck musc. weakn.
   See Section 8.3              Indications: Routine revers.of rocuronium/ vecuronium induc.  All other forms of torticollis: highly depend.on specialist knowl.
                                                              On subseq.admin.dos.may be adjust.accord.to clinic.response & side
                                neuromusc.block, immed. revers.of neuromusc.block.at 3 mins.aft.
   MYOZYME, (Sanofi) Genzyme [P/S]  rocuronium admin. In paed.populat.only indicat.for routine revers.of   effects observ. Max dos.not to exceed 1000 units. Clin.improvem.
   Alglucosidase alfa.          rocuronium induc.block.in childr. above 7 yrs.  may be expect. &lt; 1wk. aft.inj. Rep.approx.every 16 wks.as reqd.to
   Indications: Longt.enzyme replacem.ther.in pts.with confirm.Pompe   (S4) SOL FOR INJ, 44/34/0432. 200 mg/2 ml  maint.respons.but not more freq.than every 12 wks.
   dis.(acid alpha-glucosidase defic.)  721265-001: 100 mg/ml, 10x2 ml, R10 283,41  Glabellar lines: Tot.of 50 Units giv.IMI in five eq.aliquots of 10
   (S4) POWD.FOR CONC.FOR SOL.FOR INFUS. 43/31/0745.   For furth.details refer to manufact.product lit.  Units each, clin.eff.
   5 mg/ml.                                                   may last up to four mnths., do not admin.more freq. than every three
   716560-001: 1x 50 mg sngl.use vial, R6 912,68  CHAMPIX, Pfizer &  mnths. See prod.lit. for inj. tech.
   Dosage: Treatm.only by physic.exper.in Pompe dis./other inherit.  Varenicline  Axillary hyperhidrosis: Init.recommend.dos.: 100 units/axilla
   metabol.or neuromusc.dis. Reconstit./dil.&admin.accord.to manuf.  Indications: Aid to smoking cessat.in addit.to behav.modificat.  as intradem.inj.of 10 units/site at 10 sites/axilla. If desir.eff.not at-
   instruct.                    programm.x12 wks.             tain. up to max. 200 units/axilla can be admin.for subseq.injects.,
   Recomm.dos: 20 mg/kg bm admin.once every 2 wks as IV infus.   (S5) TABS, 41/34/0573, 0574  area to be inject.should be determin.beforeh.using iodine-starch
   Admin.infus.increment.init.at rate of 1 mg/kg/hr grad.incr.by 2 mg/  716491-001: start.pack, 11x0,5 mg+42x1 mg, R564,49  test, max.effect should be seen &lt; 2 wks. aft.inj., furth.applicat.not
   kg/hr every 30 mins.until.max.7 mg/kg/hr if no infus.relat. reacts.  715695-002: maint.pack, 56x1 mg, R544,33  more oft.than every 12 wks.
   Contra-indications: Safety in pregn.& lactat. not est., safety & ef-  Dosage: Treat x12 wks. Pt to set date to stop smok. 1 wk.aft.init.  Contraindications: Infect./inflammat.at propos. inj.sites, pregn.& lactat.
   fic.in ren./hepat.insuff.not est.  ther. Ther.to start 1-2 wks.bef. this date  Side effects: Itch., skin rash,generalis.weakn., fatig., flu-like syndr.,
   Side-effects: Infus.assoc.reacts., urticar., rales, bronchosp., perior-  Recomm.dos: 1 mg 2xdly follow.1 wk.tritrat: Days 1-3: 0,5 mg   pain/bruis. at inject.site, GI disords., leg/arm musc.weakn., musc.
   bit.oed., agitat., tremor, tachycard., cyanos., flush., hypertens., pallor,   once dly in even. Days 4-7: 0,5 mg 2xdly. Day 8 till end of treatm:   pain, urin. incontin., abnorm.gait, accident.injury due to fall., blurr.
   cough, tachypn., vomit., skin reacts., pyrex., rigor.  1 mg 2xdly.  vis., reduc.vis.acuity, diplop., dysphon., dyspn., aspirat., musc.weakn.,
   Special precautions: Ser.hypersens.reacts. incl. life-threat.anaphy-  If treatm.not sucessf./those who relapse another attempt is to be   neck/musculoskelet. pain, myalg., extrem.pain, musculoskelet.stiffn.,
   lact.reacts.&/card.arrest, decr. infus.rate/temp.stop infus.&/admin.  encourag.once contribut.fact.to fail.address.  musc.atrophy, jaw disord., nasopharyngit., URTI, sinusit., hypersens.,
   antihist. &/ antipyret. in case of infus.assoc.reacts., discont. ther.  Contraindications: Safety & effic.not est.in schizophren./bi-pol.  asthenop., ptosis, eyelid oed., lacrimat.incr., dry eye, musc.twitch.,
   immed.in case of sev.infus.relat. /anaphylact. reacts.& init.appropr.  disord.& maj.depress.disord., safety in pregn.& lactat.not est., not   vis. disturb., blurr.vis., eye movem.disord., prurit., rash, urticar., inject.
   med.treatm., CPR equipm.to be avail.esp.in case of card. hypertro-  recomm.in pts. und.18 yrs.  site react., compensat.sweat., aspirat.pneumon.
   phy/ signific.compromis.resp.funct., predispos.to high.risk of sev.  Side effects: Bronchit., nasopharyngit., sinusit., fung./ vir.infect., incr./  Warnings and special precautions: Use in conjunct.with
   infus.relat.reacts.in advanc. Pompe dis., safety & effic.prim.eval.in   decr.appetite, anorex., polydips., psych.disords., CNS effs., incr./decr. li-  physio./occupat.ther.as part of comprehen. treatm.program.when
   childr., ac.underly.illn., cons.pt.clinic.status bef. admin., monit.IgG   bido, atrial fibrillat., palpitat., scotoma, scleral discol., eye pain, mydrias.,   current.accept. modalit. have fail., do not exceed recomm.dos./</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page378.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page374.html">374</a>&nbsp;&nbsp;&nbsp;<a href="page375.html">375</a>&nbsp;&nbsp;&nbsp;<a href="page376.html">376</a>&nbsp;&nbsp;&nbsp;<a href="page377.html">377</a>&nbsp;&nbsp;&nbsp;<a href="page378.html">378</a>&nbsp;&nbsp;&nbsp;<a href="page379.html">379</a>&nbsp;&nbsp;&nbsp;<a href="page380.html">380</a>&nbsp;&nbsp;&nbsp;<a href="page381.html">381</a>&nbsp;&nbsp;&nbsp;<a href="page382.html">382</a>&nbsp;&nbsp;&nbsp;<a href="page383.html">383</a>&nbsp;&nbsp;&nbsp;<a href="page384.html">384</a>
             </td>
             <td width="35%"><a href="page380.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page380.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
